Meta Analysis / 医学Meta分析v2.20.0

Researchers can input study data (e.g., effect sizes, sample sizes) and obtain pooled estimates, forest plots, and heterogeneity metrics (I²) with fully reproducible R code. This streamlines systematic reviews and meta-analyses for clinical trials, saving weeks of manual work.

For researchers preparing manuscripts for journals, the skill generates publication-ready forest plots, funnel plots, and subgroup analyses that meet common reporting standards. It also supports language auto-switching to produce analysis reports in Chinese or English, catering to international journals.

Instructors can use the skill to teach meta-analysis methodologies by running live code examples and visualizations. It offers a full-featured environment covering advanced topics like network meta-analysis and diagnostic test accuracy, enhancing hands-on learning.

This skill assists in synthesizing evidence for drug efficacy and safety from multiple trials, supporting regulatory submissions, health technology assessments, and internal decision-making. Bayesian NMA capabilities allow indirect comparisons of treatment options.

Policy analysts and guideline panels can use the skill to perform comprehensive meta-analyses, including risk of bias assessment and sensitivity analyses, to inform clinical guidelines and public health policies. The TSA module helps determine sample size sufficiency in accumulating evidence.

Offer the meta-analysis skill as part of a cloud-based biostatistics platform, charging subscription fees for access to the advanced analytics modules. Revenue comes from recurring subscription fees, potentially tiered by features (e.g., basic vs. advanced NMA), for researchers and institutions.

Enable users to pay for individual meta-analysis runs without committing to a subscription. Revenue is generated per successful analysis (e.g., cost per submitted query or report), providing flexibility for occasional users.

Leverage the skill's capability to provide tailored meta-analysis services for pharmaceutical companies, academic groups, or CROs. Consultants use the tool to deliver high-quality analyses and reports, charging a project-based fee.